Montelin, Myca .
HRN: 24-08-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
CEFUROXIME 750MG (VIAL)
11/12/2023
11/19/2023
IV
240mg
Q8H
Benign Febrile Seizure; PCAP B
Checking Final Appropriateness
11/14/2023
CEFTRIAXONE 1G (VIAL)
11/14/2023
11/20/2023
IV DRIP
750mg
Q24h
BFC, PCAP
Checking Final Appropriateness
11/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/22/2023
11/29/2023
IVT
110mg
Q24
Sepsis/PCAP
Checking Final Appropriateness